There is evidence of transient drop in FEV1 following inhalation, that may be due to vehilce. There is statistical evidence for an increased incidence of severe asthma requiring MV in B2-agonists users
There is evidence of transient drop in FEV1 following inhalation, that may be due to vehilce. There is statistical evidence for an increased incidence of severe asthma requiring MV in B2-agonists users